TITLE

Pfizer Buys OTC Rights to Heartburn Drug Nexium

PUB. DATE
August 2012
SOURCE
MondayMorning;8/20/2012, Vol. 20 Issue 33, p1
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article focuses on the heartburn drug Nexium for over-the-counter use by Pfizer Inc. in New York who has agreed to acquire rights to market AstraZeneca Plc's in London, England paying 250 million US dollars up front as well as milestone and royalty payments. It states that the company has planned to begin selling the drug in the U.S. beginning in 2014, followed by other markets. It also states that as e result of this deal Pfizer is lowering its full-year earnings estimate by two cents.
ACCESSION #
79361378

 

Related Articles

  • Nexium 24HR Makes Rx-to-O-T-C Switch.  // MMR;6/9/2014, Vol. 31 Issue 9, p16 

    The article reports on the over the counter (O-T-C) availability of the drug brand Nexium 24HR (esomeprazole magnesium) from the Pfizer Inc. in the U.S. and mentions that the company acquired the global O-T-C rights to Nexium from the pharmaceutical firm AstraZeneca in August 2012.

  • Pfizer and AstraZeneca Strike Global Agreement for OTC Version of Nexium®. Cartwright, Heather // PharmaDeals Review;2012, Vol. 2012 Issue 8, p109 

    The article reports that Pfizer Inc. was granted an exclusive global rights to market proton pump inhibitor (PPI) Nexium® by AstraZeneca PLC for its approved over-the-counter (OTC) indications. It states that Pfizer is also eligible to receive a royalty payments based on product launches and...

  • Pharmaceuticals Industry Profile: Denmark.  // Pharmaceuticals Industry Profile: Denmark;Dec2006, p1 

    Presents a profile of the Pharmaceuticals industry in Denmark. Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the industry; Market forecasts; Demographics; Further reading.

  • Pharmaceuticals Industry Profile: Norway.  // Pharmaceuticals Industry Profile: Norway;Dec2006, p1 

    Presents a profile of the Pharmaceuticals industry in Norway. Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the industry; Market forecasts; Demographics; Further reading.

  • Pharmaceuticals Industry Profile: Norway.  // Pharmaceuticals Industry Profile: Norway;Nov2008, p1 

    Presents a profile of the Pharmaceuticals industry in Norway. Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the industry; Market forecasts; Demographics; Further reading.

  • Pharmaceuticals Industry Profile: Norway.  // Pharmaceuticals Industry Profile: Norway;Dec2010, p1 

    Presents a profile of the Pharmaceuticals industry in Norway. Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the industry; Market forecasts; Demographics; Further reading.

  • Pharmaceuticals Industry Profile: Sweden.  // Pharmaceuticals Industry Profile: Sweden;Dec2005, p1 

    Presents a profile of the Pharmaceuticals industry in Sweden. Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the industry; Market forecasts; Demographics; Further reading.

  • Pharmaceuticals Industry Profile: Sweden.  // Pharmaceuticals Industry Profile: Sweden;Dec2006, p1 

    Presents a profile of the Pharmaceuticals industry in Sweden. Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the industry; Market forecasts; Demographics; Further reading.

  • Pharmaceuticals Industry Profile: Sweden.  // Pharmaceuticals Industry Profile: Sweden;Dec2007, p1 

    Presents a profile of the Pharmaceuticals industry in Sweden. Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the industry; Market forecasts; Demographics; Further reading.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics